New ultrasound technique could spot hidden tendon damage in psoriatic arthritis
NCT ID NCT07188688
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study will test a special ultrasound technique called shear-wave elastography to see if it can better detect tendon inflammation (enthesitis) in people with psoriatic arthritis. Researchers will compare this method with standard ultrasound and also look at how it relates to a protein called SIRT2 and disease activity. The goal is to improve diagnosis and monitoring of this condition.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Musculoskeletal Ultrasound Device (LOGIQ P10)
- What this could lead to
- If successful, this could provide a better, non-invasive way to detect tendon inflammation in psoriatic arthritis, potentially improving diagnosis and monitoring.
- What could go wrong
- This is a small, early-stage study with only 57 participants, so results may not apply to everyone. The technique is still experimental and not yet proven to be better than standard methods.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 57 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Oct 2025
An estimate. Start dates often move.
- Expected to finish
-
Nov 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
57 participants: 19 Psoriatic arthritis patients, 19 Psoriasis-only patients and 19 healthy control.
- Ages
-
18 years and older
- Sex
-
Anyone
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients diagnosed as PsO by a dermatologist according to PASI score. * Patients diagnosed as PsA by rheumatologist according to CASPAR classification criteria for psoriatic arthritis * Adult patients of both sexes with an average \> 18 years Exclusion Criteria: * Patients with a history of metabolic disease affecting tendons. * Patients with history of surgery, injury or trauma of patellar and/or Achilles tendon. * Patients with other rheumatological diseases. * Patients below 18.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Psoriasis are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Assiut University
Asyut, 71111, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Gut bacteria may hold clues to dozens of diseases
- Can toe exercises straighten young bunions?
- Can a Job-Focused rehab program keep arthritis patients employed?
- Can a Once-Daily moisturizer help psoriasis skin? patients put it to the test
- Can an oral drug calm psoriatic arthritis? phase 3 trial puts deucravacitinib to the test
- Can a fruit acid in tiny carriers rival steroid creams for psoriasis?